SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-023461
Filing Date
2019-11-14
Accepted
2019-11-14 16:02:42
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0919_yewbiopharm.htm 10-Q 731351
2 CERTIFICATION f10q0919ex31-1_yewbiopharm.htm EX-31.1 7691
3 CERTIFICATION f10q0919ex31-2_yewbiopharm.htm EX-31.2 7679
4 CERTIFICATION f10q0919ex32_yewbiopharm.htm EX-32 3664
  Complete submission text file 0001213900-19-023461.txt   4696260

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE yewb-20190930.xml EX-101.INS 831016
6 XBRL SCHEMA FILE yewb-20190930.xsd EX-101.SCH 85768
7 XBRL CALCULATION FILE yewb-20190930_cal.xml EX-101.CAL 68841
8 XBRL DEFINITION FILE yewb-20190930_def.xml EX-101.DEF 189048
9 XBRL LABEL FILE yewb-20190930_lab.xml EX-101.LAB 470340
10 XBRL PRESENTATION FILE yewb-20190930_pre.xml EX-101.PRE 313010
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54701 | Film No.: 191219900
SIC: 0100 Agricultural Production-Crops